Barclays Maintains Overweight on Nutrien, Lowers Price Target to $81
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Benjamin Theurer maintains Nutrien (NYSE:NTR) with a Overweight and lowers the price target from $85 to $81.
Barclays analyst Benjamin Theurer maintains Nutrien (NYSE:NTR) with a Overweight and lowers the price target from $85 to $81.